Histone Deacetylase 1 Depletion Alleviates Coronary Heart Disease Via the MicroRNA-182-Mediated Transforming Growth

Shengkai Zhou1, Peng Liu, Guobao Zhang

  • 1Department of Cardiovascular Surgery, Fuwai Central China Cardiovascular Hospital, The People's Hospital of Zhengzhou University, Henan Provincial People's Hospital, Zhengzhou, Henan, P.R. China.

Insights

Histone deacetylase 1 (HDAC1) worsens coronary heart disease (CHD) by repressing miR-182, which activates the TGF-β/Smad pathway. Downregulating HDAC1 improves cardiac function and reduces injury in CHD rats.

Area of Science:

  • Molecular Biology
  • Cardiovascular Research
  • Epigenetics

Background:

  • Histone deacetylases (HDACs) regulate gene expression by controlling histone acetylation.
  • HDAC inhibitors have shown potential in suppressing cardiomyocyte growth.
  • The specific role of HDAC1 in coronary heart disease (CHD) progression requires further investigation.

Purpose of the Study:

  • To investigate the role of HDAC1 in the pathogenesis of coronary heart disease (CHD).
  • To elucidate the regulatory mechanism of HDAC1 on microRNA-182 (miR-182) expression.
  • To determine the impact of the HDAC1/miR-182 axis on the transforming growth factor (TGF)-β/Smad pathway in CHD.

Main Methods:

  • Epigenetic probe array and chromatin immunoprecipitation for HDAC1 and miR-182 analysis.
  • MicroRNA microarray to identify downstream targets of HDAC1.
  • In vivo studies in CHD rats using various biochemical and histological assays.
  • Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis and Western blot.

Main Results:

  • HDAC1 was overexpressed in CHD patients and repressed miR-182 expression in rat cardiomyocytes via deacetylation.
  • Downregulation of HDAC1 improved cardiac function, normalized lipid profiles, and reduced myocardial injury and inflammation in CHD rats.
  • miR-182 downregulation exacerbated cardiac injury in the context of HDAC1 knockdown.
  • HDAC1/miR-182 modulated the TGF-β/Smad pathway, with HDAC1 activating it and miR-182 inhibiting it.

Conclusions:

  • HDAC1 plays a crucial role in promoting CHD by repressing miR-182 expression.
  • The HDAC1-mediated repression of miR-182 leads to the activation of the TGF-β/Smad pathway, contributing to CHD progression.
  • Targeting the HDAC1/miR-182 axis presents a potential therapeutic strategy for managing coronary heart disease.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.9K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
69
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
7.6K